General Info
Naveen Krishnan is the Senior Director Venture Investments of Leaps by Bayer, responsible for developing investment cases and deal execution. With experience in various senior roles in biotechnology companies, he oversees operations, business development, clinical trials, product development, logistics, and holds board director roles for companies like Azitra. Naveen has partnered with companies such as Accent Therapeutics and Edifice Health in recent investments.
Location:
Country: United States of America
Industries:
Investment Regions: EU, NA
Investment Stages: pre-seed, seed
Website: https://leaps.bayer.com/team
angel-individual
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: very-active
AI Reasoning: Found a press release showing Naveen Krishnan joined Accent Therapeutics board in conjunction with a $75M Series C financing dated January 23, 2024. That investment date is within 6 months from the reference date, indicating recent activity. The startup involved is Accent Therapeutics.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Naveen Krishnan
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI